Clinical Trial Update: Buccal Misoprostol and Intravenous Tranexamic Acid During Emergent Cesarean Delivery [NA]

View source ↗

Summary

Clinical trial examining buccal misoprostol and intravenous tranexamic acid during emergent cesarean delivery; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cesarean Section Complications

Drugs mentioned

• Misoprostol (buccal) (misoprostol)
• Tranexamic acid (intravenous) (tranexamic acid)

Snippet

Sponsor: hany farouk | Conditions: Cesarean Section Complications | NA | Status: UNKNOWN